Clinical Trials Directory

Trials / Completed

CompletedNCT02197559

Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis

A Prospectie Cohort Study of Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis

Status
Completed
Phase
Study type
Observational
Enrollment
168 (actual)
Sponsor
Xuanwu Hospital, Beijing · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The study hypothesizes that Drug -eluting stents are more effective in preventing restenosis than Bare-metal stents after Vertebral Artery Ostium stenting

Detailed description

The vertebral artery ostium stenosis was one of the higher risk of the ischemia stroke in China. In the mean time ,more and more people accept revascularization. There are no prospective studies for comparison of prevention of restenosis after Drug -eluting stents and Bare-metal stents until now. The main aim of this study is to observe the following details: 1. Late loss in lumen diameter in follow-up ≥50% 2. Death, non -fatal stroke 30 days after stent implantation associated with antiplatelet drugs 3. Death, non -fatal stroke 12 months after stent implantation associated with antiplatelet drugs Secondary endpoint: brain, gastrointestinal and urinary system bleeding in 12 months follow-up

Conditions

Interventions

TypeNameDescription
PROCEDUREDES groupall the participants in this group will be performed with drug -eluting stents
PROCEDUREBMS groupall the participants in this group will be performed with bare-metal stents

Timeline

Start date
2014-01-01
Primary completion
2015-06-01
Completion
2016-06-01
First posted
2014-07-22
Last updated
2016-10-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02197559. Inclusion in this directory is not an endorsement.